Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Young

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Adolescent Medicine: State of the Art Reviews|October 1, 2008
Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorderJoel Young
Postgraduate Medicine|October 26, 2012
Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/hyperactivity disorderC Brendan Montano, Joel Young
Journal of Chromatography. A|December 2, 2008
Drug interactions with potential rubber closure extractables. Identification of thiol-disulfide exchange reaction products of captopril and thiuramsClaudia Corredor, Frank P Tomasella, Joel Young
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|August 26, 2003
Sequencing by hybridization by cooperating direct and reverse spectraSamuel A Heath, Franco P Preparata, Joel Young
International Journal of Pharmaceutics|June 2, 2009
Quantitative determination of trace levels of hydrogen peroxide in crospovidone and a pharmaceutical product using high performance liquid chromatography with coulometric detectionHongfei Yue, Xin Bu, Ming-Hsing Huang, et al.
Journal of Child and Adolescent Psychopharmacology|October 7, 2014
Efficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners' Parent Rating Scale-revised: Short FormJoel Young, Thomas Rugino, Ryan Dammerman, et al.
CNS Spectrums|January 26, 2010
Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorderRichard Weisler, Joel Young, Greg Mattingly, et al.
Clinical Neuropharmacology|May 8, 2012
Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioningLinda Wietecha, Joel Young, Dustin Ruff, et al.
BMJ Open|July 27, 2021
How is the medical assistance in dying (MAID) process carried out in Nova Scotia, Canada? A qualitative process model flowchart studyEllen T Crumley, Scarlett Kelly, Joel Young, et al.
BMC Psychiatry|January 30, 2013
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderGreg W Mattingly, Richard H Weisler, Joel Young, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Adolescent Medicine: State of the Art Reviews|October 1, 2008
Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorderJoel Young
Postgraduate Medicine|October 26, 2012
Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/hyperactivity disorderC Brendan Montano, Joel Young
Journal of Chromatography. A|December 2, 2008
Drug interactions with potential rubber closure extractables. Identification of thiol-disulfide exchange reaction products of captopril and thiuramsClaudia Corredor, Frank P Tomasella, Joel Young
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|August 26, 2003
Sequencing by hybridization by cooperating direct and reverse spectraSamuel A Heath, Franco P Preparata, Joel Young
International Journal of Pharmaceutics|June 2, 2009
Quantitative determination of trace levels of hydrogen peroxide in crospovidone and a pharmaceutical product using high performance liquid chromatography with coulometric detectionHongfei Yue, Xin Bu, Ming-Hsing Huang, et al.
Journal of Child and Adolescent Psychopharmacology|October 7, 2014
Efficacy of guanfacine extended release assessed during the morning, afternoon, and evening using a modified Conners' Parent Rating Scale-revised: Short FormJoel Young, Thomas Rugino, Ryan Dammerman, et al.
CNS Spectrums|January 26, 2010
Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorderRichard Weisler, Joel Young, Greg Mattingly, et al.
Clinical Neuropharmacology|May 8, 2012
Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioningLinda Wietecha, Joel Young, Dustin Ruff, et al.
BMJ Open|July 27, 2021
How is the medical assistance in dying (MAID) process carried out in Nova Scotia, Canada? A qualitative process model flowchart studyEllen T Crumley, Scarlett Kelly, Joel Young, et al.
BMC Psychiatry|January 30, 2013
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderGreg W Mattingly, Richard H Weisler, Joel Young, et al.
Pageof 2